Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
LUNA INNOVATIONS INC
SIC 8731 · Services-Commercial Physical & Biological Research
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
LUNA INNOVATIONS INC
SIC 8731 · Services-Commercial Physical & Biological Research
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
LUNA INNOVATIONS INC
SIC 8731 · Services-Commercial Physical & Biological Research
Support
about
terms
LUNA INNOVATIONS INC
CIK:
0001239819
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.23.3
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]
Revenue
$ 30,703
$ 29,153
$ 84,912
$ 77,795
Cost of revenue
13,074
12,234
35,445
30,633
Gross profit
17,629
16,919
49,467
47,162
Operating expense:
Selling, general and administrative
12,829
11,678
39,565
39,733
Research, development and engineering
2,719
2,776
8,257
7,983
Amortization of intangible assets
929
987
2,839
2,794
Total operating expense
16,477
15,441
50,661
50,510
Operating income/(loss)
1,152
1,478
(1,194)
(3,348)
Other income/(expense):
Other income
115
73
98
146
Interest expense, net
(613)
(218)
(1,566)
(442)
Total other expense, net
(498)
(145)
(1,468)
(296)
Income/(loss) from continuing operations before income taxes
654
1,333
(2,662)
(3,644)
Income tax expense/(benefit)
193
165
(723)
(527)
Net income/(loss) from continuing operations
461
1,168
(1,939)
(3,117)
Income/(loss) from discontinued operations, net of income tax expense/(benefit) of $—, $(78), $(346), and $3,205.
0
28
(1,038)
622
Gain on sale of discontinued operations, net of tax of $3,117
0
0
0
10,921
Net income/(loss) from discontinued operations
0
28
(1,038)
11,543
Net income/(loss)
$ 461
$ 1,196
$ (2,977)
$ 8,426
Net income/(loss) per share from continuing operations:
Basic (in dollars per share)
$ 0.01
$ 0.04
$ (0.06)
$ (0.10)
Diluted (in dollars per share)
0.01
0.03
(0.06)
(0.10)
Net income/(loss) per share from discontinued operations:
Basic (in dollars per share)
0
0.00
(0.03)
0.36
Diluted (in dollars per share)
0
0.00
(0.03)
0.36
Net income/(loss) per share attributable to common stockholders:
Basic (in dollars per share)
0.01
0.04
(0.09)
0.26
Diluted (in dollars per share)
$ 0.01
$ 0.04
$ (0.09)
$ 0.26
Weighted average shares:
Basic (in shares)
33,917,700
32,800,690
33,631,654
32,492,276
Diluted (in shares)
35,218,547
34,104,850
33,631,654
32,492,276
v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows used in by operating activities
Net (loss)/income
$ (2,977)
$ 8,426
Adjustments to reconcile net (loss)/income to net cash used in operating activities
Depreciation and amortization
4,092
3,993
Share-based compensation
3,219
3,204
Loss on disposal of property and equipment
281
0
Gain on sale of discontinued operations, net of tax
0
(10,921)
Deferred taxes
(998)
(3,374)
Change in assets and liabilities
Accounts receivable
(6,095)
(6,166)
Contract assets
1,145
(2,739)
Inventory
(6,520)
(6,662)
Other current assets
202
2,093
Other non-current assets
(121)
599
Accounts payable and accrued and other current liabilities
(479)
5,824
Contract liabilities
111
2,425
Other non-current liabilities
0
13
Net cash used in operating activities
(8,140)
(3,285)
Cash flows used in investing activities
Acquisition of property and equipment
(1,750)
(2,313)
Acquisition of intangible property
(95)
0
Proceeds from sale of discontinued operations
0
12,973
Acquisition of Luna Innovations Germany GmbH
0
(22,085)
Other
0
29
Net cash used in investing activities
(1,845)
(11,396)
Cash flows provided by financing activities
Payments on finance lease obligations
(37)
(36)
Proceeds from borrowings under debt obligations
10,400
22,150
Payments of debt obligations
(1,750)
(16,275)
Repurchase of common stock
(436)
(294)
Proceeds from ESPP
546
521
Proceeds from the exercise of stock options
1,272
1,160
Net cash provided by financing activities
9,995
7,226
Effect of exchange rate changes on cash and cash equivalents
(6)
(1,784)
Net increase/(decrease) in cash and cash equivalents
4
(9,239)
Cash and cash equivalents—beginning of period
6,024
17,128
Cash and cash equivalents—end of period
6,028
7,889
Supplemental disclosure of cash flow information
Cash paid for interest
1,590
209
Cash paid for income tax
$ 3,206
$ 220
v3.23.3
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:
Cash and cash equivalents
$ 6,028
$ 6,024
Accounts receivable, net
39,304
33,249
Contract assets
7,324
7,691
Inventory
43,318
36,582
Prepaid expenses and other current assets
4,207
4,328
Total current assets
100,181
87,874
Property and equipment, net
4,892
4,893
Intangible assets, net
16,143
18,750
Goodwill
26,896
26,927
Operating lease right-of-use assets
7,999
4,661
Other non-current assets
3,338
3,255
Deferred tax asset
5,645
4,647
Total assets
165,094
151,007
Current liabilities:
Current portion of long-term debt obligations
3,000
2,500
Accounts payable
10,617
8,109
Accrued and other current liabilities
14,705
16,694
Contract liabilities
4,619
4,089
Current portion of operating lease liabilities
2,069
2,239
Total current liabilities
35,010
33,631
Long-term debt obligations, net of current portion
28,887
20,726
Long-term portion of operating lease liabilities
6,178
2,804
Other long-term liabilities
407
444
Total liabilities
70,482
57,605
Commitments and contingencies (Note 11)
Stockholders’ equity:
Common stock, par value $0.001, 100,000,000 shares authorized, 35,781,127 and 34,901,954 shares issued, 33,943,453 and 33,105,080 shares outstanding at September 30, 2023 and December 31, 2022, respectively
36
35
Treasury stock at cost, 1,837,674 and 1,796,862 shares at September 30, 2023 and December 31, 2022, respectively
(6,043)
(5,607)
Additional paid-in capital
109,634
104,893
Accumulated deficit
(5,273)
(2,296)
Accumulated other comprehensive loss
(3,742)
(3,623)
Total stockholders’ equity
94,612
93,402
Total liabilities and stockholders’ equity
$ 165,094
$ 151,007